FDA-approved GLP-1 medications — semaglutide and tirzepatide — prescribed and monitored by a physician who tracks your labs, protects your muscle, and adjusts your dose to your biology. Not a subscription. A medical protocol.
.webp)
GLP-1 receptor agonists are FDA-approved for chronic weight management and work by regulating appetite and slowing gastric emptying — you feel satisfied on less, and cravings quiet down. In clinical trials of FDA-approved GLP-1 medications, patients achieved substantial, sustained weight loss when combined with lifestyle changes. Individual results vary.
Metabolic dysfunction compounds silently. Insulin resistance is measurable five to ten years before the scale shows it — and every year untreated makes the correction harder.

A physician-supervised protocol — dosing, labs, and muscle preservation managed by Dr. Sandhu and his clinical team.
.webp)




.webp)
.webp)
Results shown are individual patient outcomes. Individual results vary.

GLP-1 medications are prescription-only and are not right for everyone. The most common side effects are nausea, digestive changes, and fatigue, which typically ease as your body adjusts and as dosing is titrated properly. GLP-1 medications are not appropriate for patients with a personal or family history of medullary thyroid carcinoma or MEN 2, and require caution with a history of pancreatitis. Rapid weight loss without medical supervision can cost you muscle and nutrition — which is exactly why this program is physician-monitored. Every candidate completes a medical evaluation and baseline labs before any prescription is written.